About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Zydus Lifesciences Ltd.
BSE Code 532321
ISIN Demat INE010B01027
Book Value 210.59
NSE Code ZYDUSLIFE
Dividend Yield % 1.14
Market Cap 966739.31
P/E 16.74
EPS 57.39
Face Value 1  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Mar 2025Dec 2024Sep 2024Jun 2024
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 58196.00 25159.00 26206.00 41602.00
Total Expenditure 20469.00 18674.00 17330.00 17873.00
PBIDT (Excl OI) 37727.00 6485.00 8876.00 23729.00
Other Income 1854.00 775.00 3813.00 1066.00
Operating Profit 39581.00 7260.00 12689.00 24795.00
Interest 1554.00 972.00 959.00 1154.00
Exceptional Items 0.00 0 0 0
PBDT 38027.00 6288.00 11730.00 23641.00
Depreciation 1280.00 1316.00 1337.00 1306.00
Profit Before Tax 36747.00 4972.00 10393.00 22335.00
Tax 8610.00 266.00 2495.00 5327.00
Provisions and contingencies 0 0 0 0
Profit After Tax 28137.00 4706.00 7898.00 17008.00
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 28137.00 4706.00 7898.00 17008.00
Equity Capital 1006.00 1006.00 1006.00 1006.00
Face Value (IN RS) 1 1 1 1
Reserves    
Calculated EPS 27.97 4.68 7.85 16.91
Calculated EPS (Annualised) 111.88 18.71 31.40 67.63
No of Public Share Holdings 251609676.00 251769941.00 251769941.00 251769941.00
% of Public Share Holdings 25.01 25.02 25.02 25.02
     
PBIDTM% (Excl OI) 64.83 25.78 33.87 57.04
PBIDTM% 68.01 28.86 48.42 59.60
PBDTM% 65.34 24.99 44.76 56.83
PBTM% 63.14 19.76 39.66 53.69
PATM% 48.35 18.71 30.14 40.88
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.